Phosphinatophenylporphyrins tailored for high photodynamic efficacy
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
30259016
DOI
10.1039/c8ob01984c
Knihovny.cz E-resources
- MeSH
- Photochemotherapy * MeSH
- Photosensitizing Agents chemistry metabolism pharmacology MeSH
- HeLa Cells MeSH
- Humans MeSH
- Serum Albumin, Human metabolism MeSH
- Porphyrins chemistry metabolism pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Photosensitizing Agents MeSH
- Serum Albumin, Human MeSH
- Porphyrins MeSH
The development of effective photosensitizers is particularly attractive for photodynamic therapy of cancer. Three novel porphyrin photosensitizers functionalized with phosphinic groups were synthesized and their physicochemical, photophysical, and photobiological properties were collected. Phosphinic acid groups (R1R2POOH) attached to the porphyrin moiety (R1) contain different R2 substituents (methyl, isopropyl, phenyl in this study). The presence of phosphinic groups does not influence absorption and photophysical properties of the porphyrin units, including the O2(1Δg) productivity. In vitro studies show that these porphyrins accumulate in cancer cells, are inherently nontoxic, however, exhibit high phototoxicity upon irradiation with visible light with their phototoxic efficacy tuned by R2 substituents on the phosphorus centre. Thus, phosphinatophenylporphyrin with isopropyl substituents has the strongest photodynamic efficacy due to the most efficient cellular uptake. We demonstrate that these porphyrins are attractive candidates for photodynamic applications since their photodynamic efficacy can be easily tuned by the R2 substituent.
References provided by Crossref.org
The nanoscaled metal-organic framework ICR-2 as a carrier of porphyrins for photodynamic therapy